MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

ISIS Pharmaceuticals Company Profile (NASDAQ:ISIS)

Consensus Ratings for ISIS Pharmaceuticals (NASDAQ:ISIS) (?)
Ratings Breakdown: 6 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $71.38 (38.43% upside)

Analysts' Ratings History for ISIS Pharmaceuticals (NASDAQ:ISIS)
Show:
DateFirmActionRatingPrice TargetActions
6/24/2015Piper JaffraySet Price TargetHold$68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/23/2015Needham & Company LLCBoost Price TargetBuy$88.00 -> $91.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2015Deutsche BankSet Price TargetBuy$78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2015Piper JaffrayReiterated RatingNeutral$68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/12/2015BMO Capital MarketsReiterated RatingOutperform$95.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/11/2015Deutsche BankReiterated RatingBuy$78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2015JPMorgan Chase & Co.Boost Price TargetNeutral$65.00 -> $68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015Needham & Company LLCSet Price TargetBuy$80.00 -> $88.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2015Piper JaffraySet Price TargetHold$68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/13/2015Needham & Company LLCSet Price TargetBuy$80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2015Janney Montgomery ScottInitiated CoverageNeutral -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015Deutsche BankLower Price TargetBuy$80.00 -> $78.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2015Stifel NicolausDowngradeBuy -> Hold$66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2015Brean CapitalDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2015Piper JaffrayDowngradeOverweight -> Neutral$81.00 -> $68.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2015Needham & Company LLCSet Price TargetBuy$80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2015Needham & Company LLCBoost Price Target$80.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/16/2014JPMorgan Chase & Co.Boost Price TargetNeutral$38.00 -> $65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/10/2014Piper JaffrayBoost Price Target$62.00 -> $81.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014LaidlawBoost Price Target$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/8/2014Stifel NicolausBoost Price TargetBuy$55.00 -> $66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/25/2014LaidlawReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/20/2014Piper JaffrayBoost Price TargetOverweight$53.00 -> $62.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/26/2014Leerink SwannInitiated CoverageMarket Perform$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/28/2014BMO Capital MarketsReiterated RatingOutperform$70.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/12/2014LaidlawInitiated CoverageBuy$52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/23/2014Summer StreetReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014JPMorgan Chase & Co.Reiterated RatingNeutral$59.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2014Piper JaffrayUpgradeNeutral -> Overweight$61.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2014BMO Capital MarketsReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2014Leerink SwannBoost Price Target$33.00 -> $55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2014Jefferies GroupBoost Price Target$9.00 -> $10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/21/2014Needham & Company LLCReiterated RatingPositive$46.00 -> $61.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/20/2014Canaccord GenuityBoost Price TargetHold$32.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/22/2014Deutsche BankInitiated CoverageBuy$60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/26/2013Piper JaffrayUpgradeUnderweight -> Neutral$25.00 -> $38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/4/2013JPMorgan Chase & Co.Initiated CoverageNeutral$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/24/2013Stifel NicolausBoost Price TargetBuy$38.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/24/2013Canaccord GenuityBoost Price TargetHold$27.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/24/2013BMO Capital MarketsBoost Price TargetOutperform$31.00 -> $43.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/23/2013Goldman SachsReiterated RatingHold$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/23/2013Needham & Company LLCBoost Price TargetPositive$46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/10/2013Canaccord GenuityBoost Price TargetHold$23.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2013Goldman SachsInitiated CoverageNeutral$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/28/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha